This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected] Learn more

MLM3636 Citations (53)

Plasmid Article: Joung lab unpublished CRISPR plasmids
Joung JK Unpublished

Articles Citing MLM3636

Articles
Direct activation of human and mouse Oct4 genes using engineered TALE and Cas9 transcription factors. Hu J, Lei Y, Wong WK, Liu S, Lee KC, He X, You W, Zhou R, Guo JT, Chen X, Peng X, Sun H, Huang H, Zhao H, Feng B. Nucleic Acids Res. 2014 Apr;42(7):4375-90. doi: 10.1093/nar/gku109. Epub 2014 Feb 5. PubMed
Genetic Modification in Human Pluripotent Stem Cells by Homologous Recombination and CRISPR/Cas9 System. Xue H, Wu J, Li S, Rao MS, Liu Y. Methods Mol Biol. 2014 Mar 11. PubMed
Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining. Ghezraoui H, Piganeau M, Renouf B, Renaud JB, Sallmyr A, Ruis B, Oh S, Tomkinson AE, Hendrickson EA, Giovannangeli C, Jasin M, Brunet E. Mol Cell. 2014 Sep 18;55(6):829-42. doi: 10.1016/j.molcel.2014.08.002. Epub 2014 Sep 4. PubMed
A prominent and conserved role for YY1 in Xist transcriptional activation. Makhlouf M, Ouimette JF, Oldfield A, Navarro P, Neuillet D, Rougeulle C. Nat Commun. 2014 Sep 11;5:4878. doi: 10.1038/ncomms5878. PubMed
Mouse Genome Editing Using the CRISPR/Cas System. Harms DW, Quadros RM, Seruggia D, Ohtsuka M, Takahashi G, Montoliu L, Gurumurthy CB. Curr Protoc Hum Genet. 2014 Oct 1;83:15.7.1-15.7.27. doi: 10.1002/0471142905.hg1507s83. PubMed

Associated Plasmids

CRISPR/Cas9-mediated conversion of eGFP- into Gal4-transgenic lines in zebrafish. Auer TO, Duroure K, Concordet JP, Del Bene F. Nat Protoc. 2014 Dec;9(12):2823-40. doi: 10.1038/nprot.2014.187. Epub 2014 Nov 13. PubMed
Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs. Fu Y, Reyon D, Joung JK. Methods Enzymol. 2014;546:21-45. doi: 10.1016/B978-0-12-801185-0.00002-7. PubMed
Creating cancer translocations in human cells using Cas9 DSBs and nCas9 paired nicks. Renouf B, Piganeau M, Ghezraoui H, Jasin M, Brunet E. Methods Enzymol. 2014;546:251-71. doi: 10.1016/B978-0-12-801185-0.00012-X. PubMed
CRISPR-Cas9-Based Knockout of the Prion Protein and Its Effect on the Proteome. Mehrabian M, Brethour D, MacIsaac S, Kim JK, Gunawardana CG, Wang H, Schmitt-Ulms G. PLoS One. 2014 Dec 9;9(12):e114594. doi: 10.1371/journal.pone.0114594. eCollection 2014. PubMed

Associated Plasmids

Hypothetical gene C18orf42 encodes a novel protein kinase A-binding protein. Fukuda M, Aizawa Y. Genes Cells. 2015 Apr;20(4):267-80. doi: 10.1111/gtc.12217. Epub 2015 Feb 4. PubMed
Contributions of unique intracellular domains to switchlike biosensing by Toll-like receptor 4. Daringer NM, Schwarz KA, Leonard JN. J Biol Chem. 2015 Apr 3;290(14):8764-77. doi: 10.1074/jbc.M114.610063. Epub 2015 Feb 18. PubMed
Functional validation of mouse tyrosinase non-coding regulatory DNA elements by CRISPR-Cas9-mediated mutagenesis. Seruggia D, Fernandez A, Cantero M, Pelczar P, Montoliu L. Nucleic Acids Res. 2015 May 26;43(10):4855-67. doi: 10.1093/nar/gkv375. Epub 2015 Apr 20. PubMed
Efficient generation of hiPSC neural lineage specific knockin reporters using the CRISPR/Cas9 and Cas9 double nickase system. Li S, Xue H, Long B, Sun L, Truong T, Liu Y. J Vis Exp. 2015 May 28;(99):e52539. doi: 10.3791/52539. PubMed
Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System. Li S, Xue H, Wu J, Rao MS, Kim DH, Deng W, Liu Y. Stem Cells Dev. 2015 Dec 15;24(24):2925-42. doi: 10.1089/scd.2015.0131. Epub 2015 Nov 5. PubMed
Genome Editing in Human Cells Using CRISPR/Cas Nucleases. Wyvekens N, Tsai SQ, Joung JK. Curr Protoc Mol Biol. 2015 Oct 1;112:31.3.1-31.3.18. doi: 10.1002/0471142727.mb3103s112. PubMed
Homology-directed repair in rodent zygotes using Cas9 and TALEN engineered proteins. Menoret S, De Cian A, Tesson L, Remy S, Usal C, Boule JB, Boix C, Fontaniere S, Creneguy A, Nguyen TH, Brusselle L, Thinard R, Gauguier D, Concordet JP, Cherifi Y, Fraichard A, Giovannangeli C, Anegon I. Sci Rep. 2015 Oct 7;5:14410. doi: 10.1038/srep14410. PubMed
A puromycin selectable cell line for the enrichment of mouse embryonic stem cell-derived V3 interneurons. Xu H, Iyer N, Huettner JE, Sakiyama-Elbert SE. Stem Cell Res Ther. 2015 Nov 10;6:220. doi: 10.1186/s13287-015-0213-z. PubMed
Streptococcus thermophilus CRISPR-Cas9 Systems Enable Specific Editing of the Human Genome. Muller M, Lee CM, Gasiunas G, Davis TH, Cradick TJ, Siksnys V, Bao G, Cathomen T, Mussolino C. Mol Ther. 2015 Dec 14. doi: 10.1038/mt.2015.218. PubMed
CCR5 Disruption in Induced Pluripotent Stem Cells Using CRISPR/Cas9 Provides Selective Resistance of Immune Cells to CCR5-tropic HIV-1 Virus. Kang H, Minder P, Park MA, Mesquitta WT, Torbett BE, Slukvin II. Mol Ther Nucleic Acids. 2015 Dec 15;4:e268. doi: 10.1038/mtna.2015.42. PubMed
Generation of Highly Enriched V2a Interneurons from Mouse Embryonic Stem Cells. Iyer NR, Huettner JE, Butts JC, Brown CR, Sakiyama-Elbert SE. Exp Neurol. 2016 Jan 16. pii: S0014-4886(16)30009-7. doi: 10.1016/j.expneurol.2016.01.011. PubMed
Reprogrammable CRISPR/Cas9-based system for inducing site-specific DNA methylation. McDonald JI, Celik H, Rois LE, Fishberger G, Fowler T, Rees R, Kramer A, Martens A, Edwards JR, Challen GA. Biol Open. 2016 May 11. pii: bio.019067. doi: 10.1242/bio.019067. PubMed

Associated Plasmids

Preparation and Analysis of Native Chromatin-Modifying Complexes. Doyon Y, Cote J. Methods Enzymol. 2016;573:303-18. doi: 10.1016/bs.mie.2016.01.017. Epub 2016 Mar 16. PubMed
Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner. Cano-Rodriguez D, Gjaltema RA, Jilderda LJ, Jellema P, Dokter-Fokkens J, Ruiters MH, Rots MG. Nat Commun. 2016 Aug 10;7:12284. doi: 10.1038/ncomms12284. PubMed
Exploiting the CRISPR/Cas9 system to study alternative splicing in vivo: application to titin. Charton K, Suel L, Henriques SF, Moussu JP, Bovolenta M, Taillepierre M, Becker C, Lipson K, Richard I. Hum Mol Genet. 2016 Aug 23. pii: ddw280. PubMed
Identification of Small-Molecule PHD2 Zinc Finger Inhibitors that Activate Hypoxia Inducible Factor. Arsenault PR, Song D, Bergkamp M, Ravaschiere AM, Navalsky BE, Lieberman PM, Lee FS. Chembiochem. 2016 Dec 14;17(24):2316-2323. doi: 10.1002/cbic.201600493. Epub 2016 Nov 11. PubMed
CORALINA: a universal method for the generation of gRNA libraries for CRISPR-based screening. Koferle A, Worf K, Breunig C, Baumann V, Herrero J, Wiesbeck M, Hutter LH, Gotz M, Fuchs C, Beck S, Stricker SH. BMC Genomics. 2016 Nov 14;17(1):917. PubMed
Rewiring human cellular input-output using modular extracellular sensors. Schwarz KA, Daringer NM, Dolberg TB, Leonard JN. Nat Chem Biol. 2016 Dec 12. doi: 10.1038/nchembio.2253. PubMed

Associated Plasmids

Targeted epigenetic editing of SPDEF reduces mucus production in lung epithelial cells. Song J, Cano Rodriguez D, Winkle M, Gjaltema RA, Goubert D, Jurkowski TP, Heijink IH, Rots MG, Hylkema MN. Am J Physiol Lung Cell Mol Physiol. 2016 Dec 23:ajplung.00059.2016. doi: 10.1152/ajplung.00059.2016. PubMed
Characterization of the interplay between DNA repair and CRISPR/Cas9-induced DNA lesions at an endogenous locus. Bothmer A, Phadke T, Barrera LA, Margulies CM, Lee CS, Buquicchio F, Moss S, Abdulkerim HS, Selleck W, Jayaram H, Myer VE, Cotta-Ramusino C. Nat Commun. 2017 Jan 9;8:13905. doi: 10.1038/ncomms13905. PubMed
A ZIP6-ZIP10 heteromer controls NCAM1 phosphorylation and integration into focal adhesion complexes during epithelial-to-mesenchymal transition. Brethour D, Mehrabian M, Williams D, Wang X, Ghodrati F, Ehsani S, Rubie EA, Woodgett JR, Sevalle J, Xi Z, Rogaeva E, Schmitt-Ulms G. Sci Rep. 2017 Jan 18;7:40313. doi: 10.1038/srep40313. PubMed
Precise and efficient scarless genome editing in stem cells using CORRECT. Kwart D, Paquet D, Teo S, Tessier-Lavigne M. Nat Protoc. 2017 Feb;12(2):329-354. doi: 10.1038/nprot.2016.171. Epub 2017 Jan 19. PubMed
Exploiting the CRISPR/Cas9 system to study alternative splicing in vivo: application to titin. Charton K, Suel L, Henriques SF, Moussu JP, Bovolenta M, Taillepierre M, Becker C, Lipson K, Richard I. Hum Mol Genet. 2016 Oct 15;25(20):4518-4532. doi: 10.1093/hmg/ddw280. PubMed
Mechanisms of precise genome editing using oligonucleotide donors. Kan Y, Ruis B, Takasugi T, Hendrickson EA. Genome Res. 2017 Jul;27(7):1099-1111. doi: 10.1101/gr.214775.116. Epub 2017 Mar 29. PubMed
Sensing Self and Foreign Circular RNAs by Intron Identity. Chen YG, Kim MV, Chen X, Batista PJ, Aoyama S, Wilusz JE, Iwasaki A, Chang HY. Mol Cell. 2017 Jul 20;67(2):228-238.e5. doi: 10.1016/j.molcel.2017.05.022. Epub 2017 Jun 15. PubMed
Reconstruction of enhancer-target networks in 935 samples of human primary cells, tissues and cell lines. Cao Q, Anyansi C, Hu X, Xu L, Xiong L, Tang W, Mok MTS, Cheng C, Fan X, Gerstein M, Cheng ASL, Yip KY. Nat Genet. 2017 Oct;49(10):1428-1436. doi: 10.1038/ng.3950. Epub 2017 Sep 4. PubMed
miR-155 induces ROS generation through downregulation of antioxidation-related genes in mesenchymal stem cells. Onodera Y, Teramura T, Takehara T, Obora K, Mori T, Fukuda K. Aging Cell. 2017 Dec;16(6):1369-1380. doi: 10.1111/acel.12680. Epub 2017 Oct 2. PubMed
Evaluating different DNA binding domains to modulate L1 ORF2p-driven site-specific retrotransposition events in human cells. Ade CM, Derbes RS, Wagstaff BJ, Linker SB, White TB, Deharo D, Belancio VP, Ivics Z, Roy-Engel AM. Gene. 2018 Feb 5;642:188-198. doi: 10.1016/j.gene.2017.11.033. Epub 2017 Nov 14. PubMed
Optimized guide RNA structure for genome editing via Cas9. Xu J, Lian W, Jia Y, Li L, Huang Z. Oncotarget. 2017 Oct 7;8(55):94166-94171. doi: 10.18632/oncotarget.21607. eCollection 2017 Nov 7. PubMed
A Survey of Validation Strategies for CRISPR-Cas9 Editing. Sentmanat MF, Peters ST, Florian CP, Connelly JP, Pruett-Miller SM. Sci Rep. 2018 Jan 17;8(1):888. doi: 10.1038/s41598-018-19441-8. PubMed
An "off-the-shelf" fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies. Cooper ML, Choi J, Staser K, Ritchey JK, Devenport JM, Eckardt K, Rettig MP, Wang B, Eissenberg LG, Ghobadi A, Gehrs LN, Prior JL, Achilefu S, Miller CA, Fronick CC, O'Neal J, Gao F, Weinstock DM, Gutierrez A, Fulton RS, DiPersio JF. Leukemia. 2018 Sep;32(9):1970-1983. doi: 10.1038/s41375-018-0065-5. Epub 2018 Feb 20. PubMed
Establishment of Cell Lines Stably Expressing dCas9-Fusions to Address Kinetics of Epigenetic Editing. Goubert D, Koncz M, Kiss A, Rots MG. Methods Mol Biol. 2018;1767:395-415. doi: 10.1007/978-1-4939-7774-1_22. PubMed

Associated Plasmids

CtIP fusion to Cas9 enhances transgene integration by homology-dependent repair. Charpentier M, Khedher AHY, Menoret S, Brion A, Lamribet K, Dardillac E, Boix C, Perrouault L, Tesson L, Geny S, De Cian A, Itier JM, Anegon I, Lopez B, Giovannangeli C, Concordet JP. Nat Commun. 2018 Mar 19;9(1):1133. doi: 10.1038/s41467-018-03475-7. PubMed

Associated Plasmids

A fluorescent reporter for quantification and enrichment of DNA editing by APOBEC-Cas9 or cleavage by Cas9 in living cells. St Martin A, Salamango D, Serebrenik A, Shaban N, Brown WL, Donati F, Munagala U, Conticello SG, Harris RS. Nucleic Acids Res. 2018 May 9. pii: 4994269. doi: 10.1093/nar/gky332. PubMed

Associated Plasmids

Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells. Dastidar S, Ardui S, Singh K, Majumdar D, Nair N, Fu Y, Reyon D, Samara E, Gerli MFM, Klein AF, De Schrijver W, Tipanee J, Seneca S, Tulalamba W, Wang H, Chai YC, In't Veld P, Furling D, Tedesco FS, Vermeesch JR, Joung JK, Chuah MK, VandenDriessche T. Nucleic Acids Res. 2018 Sep 19;46(16):8275-8298. doi: 10.1093/nar/gky548. PubMed
In vitro effects of FBXW7 mutation in serous endometrial cancer: Increased levels of potentially druggable proteins and sensitivity to SI-2 and dinaciclib. Urick ME, Bell DW. Mol Carcinog. 2018 Nov;57(11):1445-1457. doi: 10.1002/mc.22867. Epub 2018 Jul 12. PubMed
Optimized Plasmid Construction Strategy for Cas9. Xu J, Li W, Hossen MM, Jia Y, Li L, Huang Z. Cell Physiol Biochem. 2018;48(1):131-137. doi: 10.1159/000491669. Epub 2018 Jul 12. PubMed
Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair. Izmiryan A, Ganier C, Bovolenta M, Schmitt A, Mavilio F, Hovnanian A. Mol Ther Nucleic Acids. 2018 Sep 7;12:554-567. doi: 10.1016/j.omtn.2018.06.008. Epub 2018 Jun 26. PubMed
Tissue-specific expression and post-transcriptional regulation of the ATPase inhibitory factor 1 (IF1) in human and mouse tissues. Esparza-Molto PB, Nuevo-Tapioles C, Chamorro M, Najera L, Torresano L, Santacatterina F, Cuezva JM. FASEB J. 2019 Feb;33(2):1836-1851. doi: 10.1096/fj.201800756R. Epub 2018 Sep 11. PubMed
Regulatory mechanisms of incomplete huntingtin mRNA splicing. Neueder A, Dumas AA, Benjamin AC, Bates GP. Nat Commun. 2018 Sep 27;9(1):3955. doi: 10.1038/s41467-018-06281-3. PubMed

Associated Plasmids

Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling. Mana-Capelli S, McCollum D. J Biol Chem. 2018 Nov 23;293(47):18230-18241. doi: 10.1074/jbc.RA118.004187. Epub 2018 Sep 28. PubMed
Inflammation-associated miR-155 activates differentiation of muscular satellite cells. Onodera Y, Teramura T, Takehara T, Itokazu M, Mori T, Fukuda K. PLoS One. 2018 Oct 1;13(10):e0204860. doi: 10.1371/journal.pone.0204860. eCollection 2018. PubMed
A bispecific immunotweezer prevents soluble PrP oligomers and abolishes prion toxicity. Bardelli M, Frontzek K, Simonelli L, Hornemann S, Pedotti M, Mazzola F, Carta M, Eckhardt V, D'Antuono R, Virgilio T, Gonzalez SF, Aguzzi A, Varani L. PLoS Pathog. 2018 Oct 1;14(10):e1007335. doi: 10.1371/journal.ppat.1007335. eCollection 2018 Oct. PubMed
CRISPR deletion of MIEN1 in breast cancer cells. Van Treuren T, Vishwanatha JK. PLoS One. 2018 Oct 4;13(10):e0204976. doi: 10.1371/journal.pone.0204976. eCollection 2018. PubMed

If you have published an article using this plasmid, please email us at [email protected] to have your article added to this page.